Delivery Order SPE2DB25D3020-SPE2DB26FWGAB
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a contract ceiling value of $1,310.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2024, for the supply of Opzelura 1.5% cream in 60-gram units, valued at $22,363.62. This firm fixed price delivery order, with an ultimate completion date of November 12, 2024, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.26 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price contract, issued on October 31, 2025, with completion by November 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units, with a ceiling value of $5,890.17 and an ultimate completion date of November 4, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 billion and extends through December...
- The Defense Logistics Agency awarded a Delivery Order (4568090195) to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,480.01 under firm fixed pricing terms, with performance to be completed by May 1, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.23 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram formulation. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by October 27, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 5, 2025, for the supply of Opzelura 1.5% Cream in 60-gram quantities. The contract is valued at $14,900.19 and carries a firm fixed price structure with no set-aside designation, indicating it was awarded through open competitive procurement. Performance will be completed by August 6, 2025, with work performed...
- The Defense Logistics Agency awarded a delivery order valued at $76,019.41 to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60gm) on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed price, non-competitive delivery order represents a specific pharmaceutical requisition fulfilled through AmerisourceBergen's existing contract vehicle with DLA. The company, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram unit, valued at $1,845.53 under a firm fixed-price contract structure. This is a non-set-aside competitive award with an ultimate completion date of October 29, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB26FWGABDelivery Order
AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on November 3, 2025, valued at $4,496.87 for the supply of Opzelura 1.5% cream (60 grams). The contract is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside procurement, indicating the opportunity was open to full and open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026. This prime IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The DLA Medical Supply Chain utilizes this contract mechanism to fulfill pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning AmerisourceBergen as a critical vendor for federal medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 11/3/25 |